Jay Parrish
Officer at Vir Biotechnology, Inc. (VIR)
Jay Parrish has filed 4 insider reports with the SEC since February 2021, as officer at Vir Biotechnology, Inc. (VIR). Jay Parrish made no open-market purchases or sales in the last 12 months. In the latest filing, on April 5, 2021, Jay Parrish sold 6,944 shares of Vir Biotechnology, Inc. (VIR) for $357K at an average of $51.40.
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- $1.28M
Companies where Jay Parrish is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 9,260 | $1.28M | $9.15 | Apr 5, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Apr 1, 2021-$357KVIRSEC Form 4: Jay Parrish exercised 6,944 units of Common Stock at a strike of $1.52 and sold $356,956 worth of Common Stock (6,944 units at $51.40)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 1, 2021-$441KVIRSEC Form 4: Jay Parrish exercised 6,944 units of Common Stock at a strike of $1.51 and sold $440,531 worth of Common Stock (6,944 units at $63.44)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 3, 2020VIRSEC Form 5: Jay Parrish gifted 212,962 units of Common Stock, decreasing ownership by 96% to 9,260 unitsForm 5Gift
- Feb 1, 2021-$485KVIRSEC Form 4: Jay Parrish exercised 6,944 units of Common Stock at a strike of $1.55 and sold $485,424 worth of Common Stock (6,944 units at $69.91)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
Compare Jay Parrish with
- Jay Parrish vs Aziz Sawaf1 shared
- Jay Parrish vs Brent Sabatini1 shared
- Jay Parrish vs Vanina de Verneuil1 shared
- Jay Parrish vs Robert J More1 shared
- Jay Parrish vs Saira Ramasastry1 shared
- Jay Parrish vs Timothy Coughlin1 shared
Other insiders at the same companies
- Brent SabatiniVIR
- Aziz SawafVIR
- Vanina de VerneuilVIR
- Robert J MoreVIR
- Saira RamasastryVIR
- Timothy CoughlinVIR
- Janet NapolitanoVIR
- Charles Elliott SigalVIR
- Jeffrey S. HatfieldVIR
- Ramy FaridVIR
- Norbert W BischofbergerVIR
- Vicki L SatoVIR
- Marianne De BackerVIR
- Jason O'ByrneVIR
- Mark EisnerVIR
- SVF Endurance (Cayman) LtdVIR
Questions about Jay Parrish
- What is Jay Parrish's role at Vir Biotechnology, Inc.?
- Jay Parrish reports to the SEC as officer at Vir Biotechnology, Inc. (VIR), according to the latest filing on April 5, 2021.
- How many shares does Jay Parrish own?
- After the latest filing that states it, Jay Parrish directly owned 9,260 shares of Vir Biotechnology, Inc. (VIR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jay Parrish bought or sold stock recently?
- The most recent open-market sale was on April 1, 2021: sold 6,944 shares of Vir Biotechnology, Inc. (VIR) for $357K at an average of $51.40.
- How do I get alerts when Jay Parrish files?
- Follow Jay Parrish on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jay Parrish (SEC CIK 0001786372). Totals count each trade once, skipping amendments whose original is on file, from Feb 2, 2021 on. View on SEC EDGAR